CiroLongobardi8 Profile Banner
Ciro Longobardi Profile
Ciro Longobardi

@CiroLongobardi8

Followers
61
Following
154
Media
2
Statuses
26

Aspirant cancer biologist with a great passion for science, sport, food, travels, literature and art. 🇮🇹🧬🔬🍕🗺️⚽🎨📚 Ph.D. student at AMC

Amsterdam, The Netherlands
Joined April 2020
Don't wanna be here? Send us removal request.
@CiroLongobardi8
Ciro Longobardi
9 months
RT @Organoids_MDPI: A Method to Study Migration and Invasion of Mouse Intestinal Organoids #mdpiorganoids via @Orga….
0
2
0
@CiroLongobardi8
Ciro Longobardi
11 months
Just out!!!!! 🎉🎉🎉🎉 .A Method to Study Migration and Invasion of Mouse Intestinal Organoids #mdpiorganoids via @Organoids_MDPI @oncodeinstitute .@CancerCenterAms.
0
0
1
@CiroLongobardi8
Ciro Longobardi
1 year
I was honoured to be one of the speaker in the plenary session of the @CancerCenterAms conference 2024! Great experience!
Tweet media one
0
1
2
@CiroLongobardi8
Ciro Longobardi
2 years
RT @CantoneIrene: #Interdisciplinary #Postdoc position available @UninaIT in #mechanobiology. Come join our neightbour lab at the Departmen….
0
3
0
@CiroLongobardi8
Ciro Longobardi
2 years
RT @CantoneIrene: #Chromatin #Epigenetic #autoimmunity #XChromosomeInactivation people: anybody looking for a #postdoc to start in 2024???👇….
0
45
0
@CiroLongobardi8
Ciro Longobardi
2 years
RT @giulia_sguazzi: Lots of fun at #EWCD2023
Tweet media one
0
1
0
@CiroLongobardi8
Ciro Longobardi
2 years
Tweet media one
0
0
0
@CiroLongobardi8
Ciro Longobardi
2 years
RT @benitezja: Please join us to the GBM PDX workshop at the 4th Glioblastoma Drug Development Summit | March 2023
Tweet card summary image
glioblastoma-drugdevelopment.com
Implementing Diverse Mechanisms Across Improved Clinical Translation to Develop Safe, Effective & Deliverable Glioblastoma Therapies
0
1
0
@CiroLongobardi8
Ciro Longobardi
4 years
RT @INSB_CNRS: #ResultatScientifique 🔎 | Le chaperon R2TP active la prolifération cellulaire par l’assemblage de nanomachines essentielles….
insb.cnrs.fr
Le chaperon R2TP recrute HSP90 pour assembler de nombreuses nanomachines cellulaires, dont les ARN polymérases et les kinases
0
8
0
@CiroLongobardi8
Ciro Longobardi
4 years
RT @FurnariLab: We are looking for a new postdoc to join our team who is interested in modeling brain cancer avatars using genetically engi….
0
14
0
@CiroLongobardi8
Ciro Longobardi
4 years
RT @Intestinal_Cell: New in @cddpress! 👋. A team of researchers from @UvA_Amsterdam and @CRUK_BI targeted antiapoptotic proteins in #organo….
0
1
0
@CiroLongobardi8
Ciro Longobardi
4 years
Great interview to @benitezja and @FurnariLab about the new paper in @NeuroOnc : "PTEN deficiency leads to proteasome addiction, a novel vulnerability in glioblastoma".
@NeuroOnc
SNO
4 years
Dr. @EvanNoch interviews Drs. @FurnariLab and Jorge Benitez about their recent paper: "PTEN deficiency leads to proteosome addiction, a novel vulnerability in glioblastoma" published online in #NeuroJournal in January 2021.
Tweet media one
0
1
3
@CiroLongobardi8
Ciro Longobardi
4 years
RT @benitezja: Thanks @NeuroOnc and @EvanNoch for the opportunity of sharing our proteasome addiction work with everyone @NBTSNewYork @theA….
0
1
0
@CiroLongobardi8
Ciro Longobardi
4 years
RT @jclinicalinvest: Cyclin A2 maintains colon homeostasis and is a prognostic factor in colorectal cancer: @CNRS.#….
0
1
0
@CiroLongobardi8
Ciro Longobardi
4 years
RT @INSB_CNRS: #ResultatScientifique 🔎 | La cycline A2, qui maintient l'homéostasie du côlon, est un facteur de pronostic dans le cancer co….
0
7
0
@CiroLongobardi8
Ciro Longobardi
5 years
Proud to be part of this work. A big thanks to my mentor and friend @benitezja💪🧬🔬.
@benitezja
Jorge Benitez
5 years
Our paper is out in collaboration with @FurnariLab @SBPdiscovery @UCSDChavezLab @CiroLongobardi8 GBM is vulnerable to proteasome inhibition due to high protein synthesis rate and autophagy deficiency @NBTStweets @NeuroOnc @BrainTumourOrg @NIHBrainTumor
0
0
6
@CiroLongobardi8
Ciro Longobardi
5 years
RT @TheCleversLab: A new organoid-derived bronchioalveolar model that was used to study SARS-CoV-2. Congrats to @jeltevdvaart and @MartLame….
0
4
0